GlaxoSmithKline Pharmaceuticals Limited — Others, 05-02-2025: Action(s) initiated or orders passed

GlaxoSmithKline Pharmaceuticals Limited has received a demand order from the Excise and Taxation officer in Punjab for Rs. 85.07 crore, stemming from alleged disallowance of certain concessional interstate sales during April to June 2017. The order includes a tax amount of Rs. 59.07 crore and interest of Rs. 25.99 crore. While the company is evaluating the order, it anticipates no immediate impact on its financial operations. This development may generate cautious investor sentiment, as stakeholders await further clarity on potential financial implications and the company’s response strategy.